drugset / Trial / NCT01462851
A Study To Observe Safety And Concentrations Of PF-05297909 And Proteins In Both Blood And Cerebrospinal Fluid After A Single Dose Of PF-05297909 In Healthy Adults
RandomizedParallel-groupDouble-blindBasic science
Summary
This study is designed to observe the safety and concentrations of PF-05297909 and proteins in both blood and cerebrospinal fluid after a single dose of PF-05297909 in healthy adults.
Timeline
- Start
- 2011-09
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-05297909 | Unknown | 25 mg | Oral |
| Subject | PF-05297909 | Unknown | 100 mg | Oral |
| Subject | PF-05297909 | Unknown | 250 mg | Oral |
| Subject | PF-05297909 | Unknown | 525 mg | Oral |
Indications
No indication recorded.